Can The COVID Approach Be Used For Other Therapeutics? FDA Speed Is Factor, Pfizer’s Bourla Says

 
• By Brenda Sandburg
  
COVID speed
Pharma execs note challenges in applying COVID-19 lessons to future therapeutics • Source: Alamy

More from Vaccines

More from Pink Sheet